SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: August 23, 2000
(Date of earliest event reported)
MEDISYS TECHNOLOGIES, INC.
(Exact name of Registrant as specified in charter)
Utah 0-21441 72-1216734
(State or other juris- (Commission (IRS Employer
diction of incorporation) File No.) Identification No.)
144 Napoleon Street, Baton Rouge, Louisiana 70802
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone no., including area code: (225) 343-8022
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On March 16, 2000, Medisys Technologies, Inc. (the "Company")
filed a Complaint against Brett Phillips, Elbert Carl Anderson,
William H. Morris, Marilyn Morris and Barbara Larkins in the United
States District Court in and for the Middle District of Louisiana,
alleging various securities law violations and related claims in
connection with the 1998 acquisition by the Company from the
defendants of Phillips Pharmatech Labs, Inc. ("Phillips"). The
Company is seeking recission of the acquisition, damages and other
relief.
Subsequently, the defendants filed a motion to dismiss the
Louisiana action based upon a provision in the 1998 acquisition
agreement giving exclusive jurisdiction of the agreement to the
State of Utah. On August 22, 2000, the Court granted defendants'
motion dismissing the Louisiana action, without prejudice. On
August 23, 2000, the Company re-filed the action in the United
States District Court for the District of Utah, Central Division.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
MEDISYS TECHNOLOGIES, INC.
Dated: August 23, 2000 By: /S/ Edward P. Sutherland
EDWARD P. SUTHERLAND
Chairman and Chief Executive Officer
